| Pancreatic Ductal Adenocarcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 78show all (up to 200) |
|---|
| → investigated in trials for | Gemcitabinesmall_molecule 66 trials (39 active) · roll-up of the cancer and its descendants | — | — | Pancreatic Ductal Adenocarcinoma | 66 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 49 trials (29 active) · roll-up of the cancer and its descendants | — | — | Pancreatic Ductal Adenocarcinoma | 49 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 26 trials (19 active) · roll-up of the cancer and its descendants | — | — | Pancreatic Ductal Adenocarcinoma | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 22 trials (15 active) · roll-up of the cancer and its descendants | — | — | Pancreatic Ductal Adenocarcinoma | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 20 trials (16 active) · roll-up of the cancer and its descendants | — | — | Pancreatic Ductal Adenocarcinoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 19 trials (17 active) · roll-up of the cancer and its descendants | — | — | Pancreatic Ductal Adenocarcinoma | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 13 trials (10 active) · roll-up of the cancer and its descendants | — | — | Pancreatic Ductal Adenocarcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 12 trials (9 active) · roll-up of the cancer and its descendants | — | — | Pancreatic Ductal Adenocarcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 11 trials (7 active) · roll-up of the cancer and its descendants | — | — | Pancreatic Ductal Adenocarcinoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 6 trials (5 active) · roll-up of the cancer and its descendants | — | — | Pancreatic Ductal Adenocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Pancreatic Ductal Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Pancreatic Ductal Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Pancreatic Ductal Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Pancreatic Ductal Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Pancreatic Ductal Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |